Gonadotropin-releasing hormone agonists for the preservation of ovarian function during chemotherapy

J Clin Oncol. 2012 Sep 10;30(26):3310-1; author reply 3312-3. doi: 10.1200/JCO.2012.42.2436. Epub 2012 May 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amenorrhea / prevention & control*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Female
  • Fertility*
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Neoadjuvant Therapy / methods*
  • Ovary / drug effects*
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone